--- title: 'Project Manager - CONTRACT at Summit Therapeutics' canonical: 'https://feeny.ai/job/project-manager-contract-summit-therapeutics-princeton-nj-mjpba1rbgzgc' type: 'job' last_seen: '2026-09-04' --- # Project Manager - CONTRACT at Summit Therapeutics - **Company:** Summit Therapeutics - **Location:** Princeton NJ, United States - **Compensation:** $150k–$170k - **Posted:** 2026-09-03 - **Last confirmed live:** 2026-09-04 - **Apply:** https://job-boards.greenhouse.io/summittherapeutics/jobs/4395025009 ## Job description About Summit: Summit Therapeutics Inc. is a biopharmaceutical oncology company with a mission focused on improving quality of life, increasing potential duration of life, and resolving serious unmet medical needs. At Summit, we believe in building a team of world class professionals who are passionate about this mission, and it is our people who drive this mission to reality. Summit’s core values include integrity, passion for excellence, purposeful urgency, collaboration, and our commitment to people. Our employees are truly the heart and soul of our culture, and they are invaluable in shaping our journey toward excellence. Summit’s team is inspired to touch and help change lives through Summit’s clinical studies in the field of oncology. Summit has multiple global Phase 3 clinical studies, including: Non-small Cell Lung Cancer (NSCLC) - HARMONi: Phase 3 clinical study which was intended to evaluate ivonescimab combined with chemotherapy compared to placebo plus chemotherapy in patients with EGFR-mutated, locally advanced or metastatic non-squamous NSCLC who were previously treated with a 3rd generation EGFR TKI. - HARMONi-3: Phase 3 clinical study which is intended to evaluate ivonescimab combined with chemotherapy compared to pembrolizumab combined with chemotherapy in patients with first-line metastatic NSCLC. - HARMONi-7: Phase 3 clinical study which is intended to evaluate ivonescimab monotherapy compared to pembrolizumab monotherapy in patients with first-line metastatic NSCLC. Colorectal Cancer (CRC) - HARMONi-GI3: Phase 3 clinical study intended to evaluate ivonescimab in combination with chemotherapy compared with bevacizumab plus chemotherapy. Ivonescimab is an investigational therapy not presently approved by any regulatory authority other than China’s National Medical Products Administration (NMPA). Summit is headquartered in Miami, Florida, and has additional offices in California, New Jersey, the UK, and Ireland. Overview of Role: The Project Manager role will be critical in ensuring operational excellence, cross-functional coordination, and launch readiness. This position serves as a partner to the launch team while acting as the primary cross-functional operational contact and liaison for effective alignment, communication flow, and governance. The role will serve as a central point of contact for operational planning, delivery, and governance of critical launch planning projects—spanning scientific communications, congress strategy, launch planning, building project management practices and post-marketing data generation supporting launch preparation. This role will focus on day-to-day project execution, ensuring defined scope, timelines, budgets, and quality objectives are met across the commercial product lifecycle. Role and Responsibilities: Strategic Project Leadership and governance - - Lead and support cross-functional planning and execution for launch readiness sub-team/s - Manage workstreams for new product launches, indication expansions, and lifecycle management. - Establish and maintain dashboards, KPIs, and governance frameworks to monitor progress, identify risks and develop mitigation solutions, and drive accountability. Cross-functional Collaboration & Process Excellence - - Partner closely with leaders in various launch functions and workstreams to ensure unified execution and prioritization. Support alignment with other launch project management team members to enhance project management effectiveness through collaboration - Champion, develop and manage planning tools for various business processes Vendor Management: - - Manage relationships with key vendors and external partners to ensure high-quality, on-time, and on-budget delivery. Project management: - - Contribute to developing robust project management tools, processes for launch and day-to-day operations. - Partner with other project managers to develop, support and manage periodic launch management dashboards, meeting materials and actively manage functional, sub-teams and work-streams meetings for effective launch management - All other duties as assigned. Experience, Education and Specialized Knowledge and Skills: - Bachelor’s (BS) degree required; advanced degree (MS, MBA, PharmD, PhD) or PMP certification preferred. - Minimum of 5+ years of experience in project management, operational excellence, reporting, and performance management within biopharmaceutical or life sciences organizations. - Minimum of 5+ years of direct project management experience supporting commercial or medical affairs - Prior experience in pre-commercial or early commercial biotech/pharma strongly preferred. - Proven ability to translate complex data into executive-ready insights. - Expertise in project management and process improvement methodologies (PMP, Lean, Six Sigma, Agile). - Strong analytical mindset - Budget and vendor management experience - Change leadership in fast-paced, evolving environments - Proven ability to influence senior stakeholders and drive accountability without direct authority. - Willingness to travel 30-50% of the time. This is the pay for this position Pay Transparency $150,000—$170,000 USD Actual compensation packages are based on several factors that are unique to each candidate, including but not limited to skill set, depth of experience, certifications, and specific work location. This may be different in other locations due to differences in the cost of labor. The total compensation package for this position may also include bonus, stock, benefits and/or other applicable variable compensation. Summit does not accept referrals from employment businesses and/or employment agencies in respect of the vacancies posted on this site. All employment businesses/agencies are required to contact Summit’s Talent Acquisition team at recruiting@smmttx.com to obtain prior written authorization before referring any candidates to Summit. Summit Therapeutics Inc. is an Equal Opportunity Employer and takes pride in creating and maintaining diverse environment. We do not discriminate in recruitment, hiring, training or promotion or any other employment practices for reasons of race, color, religion, gender, national origin, age, sexual orientation, marital or veteran status, disability, or any other legally protected status. ## About Summit Therapeutics ## Company Overview - **One-liner**: Summit Therapeutics Inc. is a biopharmaceutical oncology company focused on discovering, developing, and commercializing novel bispecific antibody therapies, with its lead candidate ivonescimab targeting PD-1 and VEGF for multiple solid tumors. - **Entity Type**: Public (NASDAQ: SMMT) - **Headquarters**: Miami, Florida, USA (with additional offices in Palo Alto, CA; Princeton, NJ; Oxford, UK; and Dublin, Ireland) - **Founded**: 2003 - **Founders**: Not publicly disclosed on the company website; the company was founded in 2003. ## Core Business - **Primary industry**: Biopharmaceuticals / Oncology - **Target customers**: B2B (healthcare providers, patients, and caregivers) with a focus on resolving serious unmet medical needs in oncology - **Mission statement**: "To resolve serious, unmet medical needs for the betterment of overall human health." [smmttx.com](https://smmttx.com/company/about-us/default.aspx) ## Products & Services - **Ivonescimab (SMT112)**: A novel, potential first-in-class investigational bispecific antibody targeting both PD-1 and VEGF. It is designed to combine immunotherapy (PD-1 blockade) with anti-angiogenesis (VEGF blockade) into a single molecule. Currently being studied in several global Phase 3 clinical trials for non-small cell lung cancer (NSCLC), colorectal cancer (CRC), and head and neck squamous cell carcinoma (HNSCC). Licensed from Akeso, Inc. (HKEX: 9926.HK) for territories including the U.S., Canada, Europe, Japan, Latin America, the Middle East, and Africa. [smmttx.com](https://smmttx.com/pipeline/default.aspx) ## Market Standing - **Valuation/Market Cap**: Approximately $2.7 billion (as of recent data) [linkedin.com](https://www.linkedin.com/company/summit-therapeutics) - **Key Metric**: Annual revenue of approximately $705,000 (reported). The company is pre-commercialization and heavily investing in R&D. Total funding raised since IPO (2015) is not disclosed, but the company has a strong cash position from equity offerings. - **Notable Investors/Partners**: Akeso, Inc. (key licensing partner for ivonescimab). The company is publicly traded with institutional and retail investors. - **Growth Signals**: - Headcount grew 72.5% year-over-year to 244 employees. [linkedin.com](https://www.linkedin.com/company/summit-therapeutics) - Multiple global Phase 3 trials actively recruiting (HARMONi, HARMONi-3, HARMONi-7, HARMONi-GI3, ILLUMINE). - Over 4,000 patients have been treated with ivonescimab across all clinical trials globally. [smmttx.com](https://smmttx.com/pipeline/default.aspx) - Achieved Great Place to Work® Certification. [smmttx.com](https://smmttx.com/careers/careers-overview/default.aspx) ## Competitive Advantages - **Novel Mechanism**: Ivonescimab is a first-in-class bispecific antibody targeting both PD-1 and VEGF simultaneously, potentially offering superior efficacy and fewer side effects compared to combination therapies. - **Speed and Execution**: The company emphasizes "high-speed execution in commercialization" and has rapidly initiated multiple Phase 3 trials. - **Global Reach**: Licensed territories cover major markets (U.S., Canada, Europe, Japan, Latin America, Middle East, Africa) with a strong partner (Akeso) in the rest of the world. - **Strong Balance Sheet**: With a $2.7B market cap and public listing, the company has access to capital markets to fund its pipeline. ## Strategic Focus - **Current priorities**: Advancing ivonescimab through Phase 3 clinical trials across multiple solid tumor indications (NSCLC, CRC, HNSCC), with the goal of regulatory approval and commercialization. - **Future direction**: Expanding the pipeline into additional solid tumors and leveraging the bispecific platform for future therapies. The company is focused on becoming a leading oncology player. - **Near-term milestones**: Data readouts from ongoing Phase 3 trials, potential regulatory submissions, and building commercial infrastructure. ## Why Work Here - **Culture**: The company has achieved Great Place to Work® Certification, indicating a positive, supportive, and fulfilling work environment. Core values include Commitment to People, Integrity, Passion for Excellence, Purposeful Urgency, Accountability, and Collaboration. [smmttx.com](https://smmttx.com/careers/careers-overview/default.aspx) - **Work Environment**: Fast-paced, high-energy atmosphere focused on innovation and collaboration. The company emphasizes "making a significant difference in patients’ lives." - **Benefits (U.S.)**: - 401(k) with 6% employer match - Employee Stock Purchase Plan (ESPP) with 15% discount up to the annual federal limit - Flexible Spending Account - Commuter Benefit - Onsite lunch provided - **Benefits (U.K.)**: - Private Medical Insurance - Employee Assistance Program - Life Assurance Policy - Company Pension Contributions - ESPP - **Remote/Hybrid Policy**: Not explicitly stated, but multiple office locations suggest a hybrid or on-site presence is expected for many roles. - **Open Roles**: 25 active job postings (as of recent data) including Senior Director of Sales Operations, Clinical Scientists, Medical Science Liaisons, and Drug Product MSAT roles. [greenhouse.io](https://job-boards.greenhouse.io/summitherrapeutics) - **Headcount Growth**: 72.5% year-over-year growth signals a scaling organization with opportunities for career advancement. ## Sources 1. [smmttx.com - About Us](https://smmttx.com/company/about-us/default.aspx) 2. [smmttx.com - Investor Relations Overview](https://www.smmttx.com/overview/default.aspx) 3. [smmttx.com - Pipeline](https://smmttx.com/pipeline/default.aspx) 4. [smmttx.com - Careers Overview](https://smmttx.com/careers/careers-overview/default.aspx) 5. [linkedin.com - Summit Therapeutics Company Page](https://www.linkedin.com/company/summit-therapeutics) 6. [greenhouse.io - Summit Therapeutics Careers](https://job-boards.greenhouse.io/summitherrapeutics) ## Other roles at Summit Therapeutics - [Director, Commercial Analytics & Information](https://feeny.ai/job/director-commercial-analytics-information-summit-therapeutics-princeton-4sy7b3h9tjvz) — Princeton, NJ - [Director, Marketing Operations](https://feeny.ai/job/director-marketing-operations-summit-therapeutics-princeton-5kjc188q3z1y) — Princeton, NJ - [Senior Manager, CRM IT](https://feeny.ai/job/senior-manager-crm-it-summit-therapeutics-princeton-nj-9q5d6bn5sa0f) — Princeton NJ, United States - [IT Business Analyst - G&A](https://feeny.ai/job/it-business-analyst-g-a-summit-therapeutics-palo-alto-8xxzscj7r2ez) — Palo Alto, CA - [IT Helpdesk Analyst](https://feeny.ai/job/it-helpdesk-analyst-summit-therapeutics-palo-alto-xkn1kh9je3fc) — Palo Alto, CA - [Associate Director, Project Management - Medical Affairs (Princeton, NJ or Palo Alto, CA)](https://feeny.ai/job/associate-director-project-management-medical-affairs-princeton-nj-or-palo-alto-h21rbxapf222) — Princeton NJ, United States - [Senior Medical Science Liaison (South)](https://feeny.ai/job/senior-medical-science-liaison-south-summit-therapeutics-united-states-jmrft1h5njy5) — United States - [Senior Medical Science Liaison (Texas)](https://feeny.ai/job/senior-medical-science-liaison-texas-summit-therapeutics-united-states-1nxejb2p96nq) — United States - [Senior Medical Science Liaison (Northeast)](https://feeny.ai/job/senior-medical-science-liaison-northeast-summit-therapeutics-united-states-kz9wzmdv6wgq) — United States - [Senior Medical Science Liaison (Mountain West)](https://feeny.ai/job/senior-medical-science-liaison-mountain-west-summit-therapeutics-united-states-4zp7v9kdvj58) — United States